Skip to main content
. Author manuscript; available in PMC: 2019 Apr 15.
Published in final edited form as: J Immunol. 2018 Feb 28;200(8):2535–2541. doi: 10.4049/jimmunol.1701587

Table I.

Demographics of 20 lung transplant recipients

Clinical features BOS (n=10) Stable (n=10)
Mean recipient age at transplant, years 49±12 54±8
Male sex 5(50%) 5(50%)
Race
 White 10(100) 9(90)
 African-American 0(0) 1(10)
End-stage lung disease
 Cystic fibrosis 5(50) 1(10)
 Idiopathic pulmonary fibrosis 3(30) 0(0)
 Chronic obstructive pulmonary disease 1(10) 7(70)
 Other 1(10) 2(20)
HLA mismatch
 A 1.5±0.5 1.4±0.5
 B 1.8±0.4 1.6±0.5
 DR 1.9±0.3 1.3±0.9
Bilateral LTx 10(100) 10(100)
Mean time from LTx to sampling, months 17.3±8.2 24.4±10.7
Mean time from LTx to BOS onset, months 16.2±8.9 N/A
*

Values presented as n (%), unless otherwise noted.

Abbreviations: BOS: bronchiolitis obliterans syndrome, HLA, human leukocyte antigen; LTx, lung transplantation; N/A, not applicable.